Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem [Phase 2]
Phase 2 safety lead-in trial evaluating the addition of a repurposed drug to the lenalidomide plus pembrolizumab combination in advanced end…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
Clinical trial update describing the role of oncovascular surgery in treating advanced gynecologic cancers, sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line [Phase 3]
A Phase 3 clinical trial in MMR-deficient endometrial cancer is evaluating first-line chemotherapy versus dostarlimab. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients [Phase 3]
Phase 3 trial evaluating prevention and treatment of chemotherapy-induced nausea and vomiting in gynecologic cancer patients treated with th…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers [Phase 1, Phase 2]
Regeneron is conducting a Phase 1/2 trial of REGN4018 (Ubamatamab) alone or in combination with cemiplimab in adults with recurrent MUC16-ex…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of sacituzumab govitecan in combination with cisplatin for platinum-sensitive recurrent o…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Generation of Endometrial Carcinoma Organoids
The trial is recruiting to generate organoids from endometrial carcinoma tissue, sponsored by Regina Elena Cancer Institute.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a PD-1 inhibitor in combination with neoadjuvant chemotherapy for advanced endometrial cancer (endome…
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]
A Phase 1 study of BLU-222 in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Serum Trace Element Levels in Some Gynecological Diseases [NA]
Clinical trial update from Cumhuriyet University indicates a completed study examining serum trace element levels in gynecological diseases,…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating REGN5668 with cemiplimab, cemiplimab plus fianlimab, or ubamatamab in adult women with ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Strive Cardio for Endometrial Cancer Survivors [NA]
The Strive Cardio trial for endometrial cancer survivors has completed.
-
CLINICAL_TRIALS other · 2025-11-19Clinical Trial Update: Study of AVZO-021 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update shows AVZO-021 is in Phase 1/2 for advanced solid tumors including HR+/HER2- breast cancer and several gynecologi…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial [NA]
This clinical trial aims to improve health behaviours for life after Endometrial cancer and is currently recruiting. The study focuses on be…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion [NA]
Clinical trial update describing a study on education for patients requiring a digestive stoma for fecal diversion, applicable to several co…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer [NA]
A clinical trial comparing OSNA and ultrastaging for detecting sentinel lymph node metastasis in endometrial cancer; recruitment is currentl…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
This completed study investigates the prevalence of HER2 IHC 3+ and characterizes clinicopathologic features of gynecologic cancers in Taiwa…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 [Phase 1, Phase 2]
A phase 1/2 trial evaluating afuresertib in combination with sintilimab and chemotherapy in selected solid tumors resistant to prior PD-1/PD…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer [Phase 2]
A Phase 2 trial is evaluating the combination of Nab-Sirolimus with Letrozole for advanced or recurrent endometrioid endometrial cancer. The…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer [NA]
A clinical trial investigating nodal sampling in endometrial cancer is currently recruiting under NCT06677112.
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Multimedia Aid for Genetic Testing in Gynecologic Oncology [NA]
A clinical trial update about a multimedia aid to improve genetic testing uptake in gynecologic cancers. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Study of ART0380 in Patients With Biologically Selected Solid Tumors [Phase 2]
A Phase 2 study of ART0380 in biologically selected solid tumors, including recurrent endometrial cancer, was terminated.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]
A Phase II, single-arm trial evaluating everolimus (RAD001) in combination with letrozole and metformin for advanced or recurrent endometria…